Desq Long
Sign in

Company

CYTOKINETICS INC

CYTK · CIK 0001061983

SEC FORM 4
$27,300.00

CYTOKINETICS INC (CYTK)

Acquisition (code M) of 3,500 shares at $7.80 per share.

Reporting Person Malik Fady Ibraham · Officer Title EVP Research & Development · Transaction Code M

Traded Sep 22, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001061983-26-000096 · filed 2026-09-22 · View filing →

SEC FORM 4
$239,015.00

CYTOKINETICS INC (CYTK)

Sale of 3,500 shares at $68.29 per share.

Reporting Person Malik Fady Ibraham · Officer Title EVP Research & Development · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001061983-26-000096 · filed 2026-09-22 · View filing →

SEC FORM 4
$6,789,209.58

CYTOKINETICS INC (CYTK)

Sale of 97,926 shares at $69.33 per share.

Reporting Person Blum Robert I · Officer Title President & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001061983-26-000094 · filed 2026-09-15 · View filing →

SEC FORM 4
$72,130.00

CYTOKINETICS INC (CYTK)

Sale of 1,000 shares at $72.13 per share.

Reporting Person Landry Robert E · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001061983-26-000095 · filed 2026-09-15 · View filing →

SEC FORM 4
$79,500.00

CYTOKINETICS INC (CYTK)

Acquisition (code M) of 7,500 shares at $10.60 per share.

Reporting Person Blum Robert I · Officer Title President & CEO · Transaction Code M

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001061983-26-000094 · filed 2026-09-15 · View filing →

SEC FORM 4
$550,800.00

CYTOKINETICS INC (CYTK)

Sale of 7,500 shares at $73.44 per share.

Reporting Person Blum Robert I · Officer Title President & CEO · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001061983-26-000094 · filed 2026-09-15 · View filing →

SEC FORM 4
$74,660.00

CYTOKINETICS INC (CYTK)

Sale of 1,000 shares at $74.66 per share.

Reporting Person Landry Robert E · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001061983-26-000093 · filed 2026-09-11 · View filing →

SEC FORM 4
$27,300.00

CYTOKINETICS INC (CYTK)

Acquisition (code M) of 3,500 shares at $7.80 per share.

Reporting Person Malik Fady Ibraham · Officer Title EVP Research & Development · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001061983-26-000092 · filed 2026-09-08 · View filing →

SEC FORM 4
$264,110.00

CYTOKINETICS INC (CYTK)

Sale of 3,500 shares at $75.46 per share.

Reporting Person Malik Fady Ibraham · Officer Title EVP Research & Development · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001061983-26-000092 · filed 2026-09-08 · View filing →

SEC FORM 4
$357,400.00

CYTOKINETICS INC (CYTK)

Sale of 5,000 shares at $71.48 per share.

Reporting Person PARSHALL B LYNNE · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001061983-26-000091 · filed 2026-09-01 · View filing →

SEC FORM 4
$79,500.00

CYTOKINETICS INC (CYTK)

Acquisition (code M) of 7,500 shares at $10.60 per share.

Reporting Person Blum Robert I · Officer Title President & CEO · Transaction Code M

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001061983-26-000089 · filed 2026-08-31 · View filing →

SEC FORM 4
$526,800.00

CYTOKINETICS INC (CYTK)

Sale of 7,500 shares at $70.24 per share.

Reporting Person Blum Robert I · Officer Title President & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001061983-26-000089 · filed 2026-08-31 · View filing →

SEC FORM 4
$232,600.00

CYTOKINETICS INC (CYTK)

Acquisition (code M) of 10,000 shares at $23.26 per share.

Reporting Person Callos Andrew · Officer Title EVP, Chief Commercial Officer · Transaction Code M

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001061983-26-000090 · filed 2026-08-31 · View filing →

SEC FORM 4
$702,400.00

CYTOKINETICS INC (CYTK)

Sale of 10,000 shares at $70.24 per share.

Reporting Person Callos Andrew · Officer Title EVP, Chief Commercial Officer · Transaction Code S

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001061983-26-000090 · filed 2026-08-31 · View filing →

SEC FORM 4
$27,300.00

CYTOKINETICS INC (CYTK)

Acquisition (code M) of 3,500 shares at $7.80 per share.

Reporting Person Malik Fady Ibraham · Officer Title EVP Research & Development · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001061983-26-000088 · filed 2026-08-18 · View filing →

SEC FORM 4
$265,370.00

CYTOKINETICS INC (CYTK)

Sale of 3,500 shares at $75.82 per share.

Reporting Person Malik Fady Ibraham · Officer Title EVP Research & Development · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001061983-26-000088 · filed 2026-08-18 · View filing →

STOCK ACT PTR
$1,001 - $15,000

CYTOKINETICS INC (CYTK)

Purchase.

Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock

Traded Jun 30, 2026 · Disclosed Jul 2, 2026

Source: House Clerk PTR · 20034906 · filed 2026-07-02 · View filing →